Mayssam H. Ali Ph.D.

Associate

Mayssam Ali’s practice includes client counseling, patent litigation, and patent prosecution (foreign and domestic), primarily in the chemical, pharmaceutical, and biotechnology sectors. Dr. Ali has substantial experience in due diligence and prelitigation investigations. She has also worked on various aspects of patent infringement and trade secret misappropriation litigation.

Dr. Ali joined Finnegan in 2005, after completing her Ph.D. in organic chemistry. During her graduate studies, Dr. Ali designed and biophysically characterized oligomeric peptides with protein-like properties that constitute models for the study of natural proteins. She also conducted graduate research in the field of organometallic chemistry.

Professional Activities

• American Bar Association
• Boston Patent Law Association
• American Chemical Society
• American Association for the Advancement of Science

Select Publications

• Coauthor. "Caveat Venditor: Advance Planning for Startup Technology Companies," Bloomberg Law Reports, Oct. 17, 2011.
• Coauthor. "Preparing Your Startup's Patent Portfolio for Sale," VentureBeat, Sept. 1, 2011.
• Coauthor, "Design of a Heterospecific, Tetrameric, 21-Residue Miniprotein with Mixed a/b Structure," Structure, 2005.
• Coauthor, "X-ray Structure Analysis of a Designed Oligomeric Miniprotein Reveals a Discrete Quaternary Architecture," Proceedings of the National Academy of Sciences of the United States of America, 2004.
• Coauthor, "Enantioselective Synthesis and Application of the Highly Fluorescent and Environment-Sensitive Amino acid 6-(2-dimethylaminonaphthoyl) Alanine (DANA)," Chemical Communications, 2002.
• Coauthor, "An Improved Method for the Palladium-Catalyzed Amination of Aryl Iodides," Journal of Organic Chemistry, 2001.